BioPlus Acquisition (BIOS) stock forecast for 2027
Last update: October 1, 2022 (07:40)Sector: Financial
The share price of BioPlus Acquisition Corp. (BIOS) now
What analysts predict:: $20
52-week high/low: $10.14 / $9.78
50/200 Day Moving Average: $10.01 / $9.94
This figure corresponds to the average price over the previous 50/200 days. For BioPlus Acquisition stocks, the 50-day moving average is the support level today.
For BioPlus Acquisition stocks, the 200-day moving average is the support level today.
Are you interested in BioPlus Acquisition stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioPlus Acquisition stock price in 2027. How much will one BioPlus Acquisition share be worth in 2027?
Is it worth taking profit / loss on BioPlus Acquisition stock now or waiting? What are analysts' forecasts for BioPlus Acquisition stock?
We forecast BioPlus Acquisition stock performance using neural networks based on historical data on BioPlus Acquisition stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The BioPlus Acquisition stock prediction results are shown below and presented as a graph, table and text information.
BioPlus Acquisition stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for BioPlus Acquisition analysts is $20.
Today 200 Day Moving Average is the support level (9.94 $).
50 Day Moving Average is the support level (10.01 $).
Historical and forecast chart of BioPlus Acquisition stock
The chart below shows the historical price of BioPlus Acquisition stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioPlus Acquisition stock price can be found in the table below.
BioPlus Acquisition (BIOS) Forecast for 2027
BioPlus Acquisition information and performance
BioPlus Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 11, 2021 and is headquartered in New York, NY.
BioPlus Acquisition Address
260 MADISON AVENUE, SUITE 800, NEW YORK, NY, UNITED STATES
Market Capitalization: 294 557 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 23560000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
BioPlus Acquisition price target for 2021 by month
Target values for the price of one BioPlus Acquisition share for Jan 2027.
Pessimistic target level: 17.40
Optimistic target level: 19.35
Target values for the price of one BioPlus Acquisition share for Feb 2027.
Pessimistic target level: 16.91
Optimistic target level: 18.56
Target values for the price of one BioPlus Acquisition share for Mar 2027.
Pessimistic target level: 16.69
Optimistic target level: 18.74
Target values for the price of one BioPlus Acquisition share for Apr 2027.
Pessimistic target level: 15.53
Optimistic target level: 16.84
Target values for the price of one BioPlus Acquisition share for May 2027.
Pessimistic target level: 15.48
Optimistic target level: 17.15
Target values for the price of one BioPlus Acquisition share for Jun 2027.
Pessimistic target level: 14.87
Optimistic target level: 16.21
Target values for the price of one BioPlus Acquisition share for Jul 2027.
Pessimistic target level: 15.36
Optimistic target level: 16.82
Target values for the price of one BioPlus Acquisition share for Aug 2027.
Pessimistic target level: 14.54
Optimistic target level: 16.40
Target values for the price of one BioPlus Acquisition share for Sep 2027.
Pessimistic target level: 14.52
Optimistic target level: 15.92
Target values for the price of one BioPlus Acquisition share for Oct 2027.
Pessimistic target level: 14.64
Optimistic target level: 16.41
Related stocks from Financial sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.